Company news
DRI Healthcare Trust news in 2024
DRI Healthcare Trust's news releases, calls and decks from 2024, newest first.
DRI Healthcare Trust Declares Special Unit Distribution
December 20, 2024
DRI Healthcare Trust Reports Third Quarter 2024 Results
November 6, 2024
DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals
November 4, 2024
DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities
November 1, 2024
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024
October 11, 2024
DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)
October 3, 2024
DRI Healthcare Trust Reports Second Quarter 2024 Results
August 6, 2024
DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes
July 8, 2024
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024
July 3, 2024
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency
July 2, 2024
DRI Healthcare Trust Reports First Quarter 2024 Results
May 6, 2024
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
April 23, 2024
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 7, 2024
April 16, 2024
DRI Healthcare Trust Announces Refinancing of Preferred Securities
April 15, 2024
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
March 26, 2024
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results
February 28, 2024
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2023 Earnings Call and Webcast on February 29, 2024
February 8, 2024
DRI Healthcare Trust Announces the Expansion of its Royalty Entitlement on the US Net Sales of Omidria®, Updates Deployment and CAGR Guidance
February 1, 2024
Decks in 2024
- Investor Presentation (December 2024)
Investor deck · 46 slides · December 2024
- Q3 2024 Earnings Presentation
Earnings · 17 slides · Nov 7, 2024
- Q2 2024 Earnings Presentation
Earnings · 16 slides · Aug 7, 2024
- Q2 2024 Earnings Presentation
Earnings · 44 slides · Aug 1, 2024
- Investor Presentation (June 2024)
Investor deck · 39 slides · June 2024
- Investor Presentation (June 2024)
Investor deck · 40 slides · June 2024
- Q1 2024 Earnings Presentation
Earnings · 22 slides · May 7, 2024
- Investor Presentation (May 2024)
Investor deck · 40 slides · May 2024
- 2024 Bloom Burton Healthcare Investor Conference
Conference · 24 slides · Apr 17, 2024
- Investor Presentation (March 2024)
Investor deck · 37 slides · March 2024
- Q4 2023 Earnings Presentation
Earnings · 22 slides · Feb 29, 2024
- Investor Presentation (February 2024)
Investor deck · 36 slides · February 2024